BerandaSNG • LON
add
Synairgen plc
Tutup sebelumnya
GBXÂ 2,25
Rentang hari
GBXÂ 1,95 - GBXÂ 2,49
Rentang tahun
GBXÂ 1,89 - GBXÂ 7,22
Kapitalisasi pasar
10,92Â jt GBP
Volume Rata-Rata
757,58Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
LON
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (GBP) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 1,95Â jt | -29,14% |
Laba bersih | -1,63Â jt | 31,28% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -1,95Â jt | 28,75% |
Tarif pajak efektif | 10,92% | — |
Neraca
Total aset
Total liabilitas
| (GBP) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 8,59Â jt | -19,19% |
Total aset | 10,64Â jt | -43,12% |
Total liabilitas | 1,08Â jt | -60,69% |
Total ekuitas | 9,56 jt | — |
Saham yang beredar | 201,37 jt | — |
Harga terhadap nilai buku | 0,45 | — |
Tingkat pengembalian aset | -45,90% | — |
Tingkat pengembalian modal | -51,07% | — |
Arus Kas
Perubahan kas bersih
| (GBP) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -1,63Â jt | 31,28% |
Kas dari operasi | -1,84Â jt | 30,36% |
Kas dari investasi | 882,00Â rb | 88.100,00% |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | -962,50Â rb | 63,64% |
Arus kas bebas | -1,13Â jt | 24,89% |
Tentang
Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic. The company is developing an inhaled formulation of interferon-beta for severe viral respiratory diseases including COVID-19.
Richard Marsden was appointed chief executive officer in September 2009. Wikipedia
Didirikan
2003
Situs
Karyawan
36
